Eton Pharmaceuticals, Inc. (ETON)
Latest financial period: June 30, 2026
Filed with the SEC: August 13, 2026
Estimated earnings date: November 5, 2026
Profit #73 of 1480 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| ROIC | 42.5% | 4.1% | -1.9% |
Growth #147 of 1480 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| Sales andOCF growth | 57.4% | 86.5% | 129.5% | 127.2% |
Payout #1116 of 1480 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| Shareholderdistributions/ net income | 0% | 0% | 0% |
Safety #1274 of 1480 companies
| Balance | Stability | |
|---|---|---|
| Equity/assets andOCF stability | 34.7% | 0.4% |
Price #1259 of 1480 companies
| Earnings | FCF | |
|---|---|---|
| Earnings andFCF yield | $0.80 | $0.93 |
